Global Commission On Drug Policy

What Global Commission On Drug Policy does

The Global Commission on Drug Policy is a non-profit advocacy organization founded in 2011 and headquartered in Geneva, Switzerland. It operates with a small operational team of 1-10 employees and is dedicated to advocating for evidence-based and human rights-focused reform of global drug laws and policies. The Commission's work centers on engaging with international and national policy frameworks to shift drug control approaches toward public health and human rights considerations rather than purely punitive enforcement.

As a policy commission rather than a commercial enterprise, the organization does not sell products or services in the traditional sense. Its 'output' consists of position papers, policy briefs, public statements, and convening activities directed at policymakers, multilateral institutions (particularly those accessible from its Geneva base), and civil society stakeholders. Its business model is consistent with a grant- and donation-funded non-profit, though no specific funding sources, donor data, or financial figures are disclosed in the available data.

No proprietary technology, AI/ML capabilities, customer-facing products, or commercial partnerships are documented. The available firmographic and operational data is minimal — the third-party data source returned only a loading page with no substantive content. Accordingly, deeper analysis of revenue mechanics, technology stack, partnerships, and management structure is constrained by the thin data set.

Name

Global Commission On Drug Policy

Website

https://globalcommissionondrugs.org

Company type

Private

Founded year

2011

Headcount range

1–10 employees

Short description

The Global Commission on Drug Policy is a Geneva-based non-profit founded in 2011 that advocates for evidence-based, human rights-focused reform of global drug laws and policies, targeting policymakers and multilateral institutions.

Ownership category

akta.pro rank

Product category

Drug Policy Advocacy

NAICS

International Affairs (92812), International Affairs (928120)

SIC

Services-Membership Organizations (8600), International Affairs (9721)

akta.pro primary industry

Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)

akta.pro secondary industries

Public Health Strategy, Policy & Legislation (HLAJAMAA), Controlled Substances & Narcotics Regulators (HLAJADAK), Global Health & Population Intergovernmental Bodies (BPADAAAD)

Keywords

• Drug policy reform
• Harm reduction advocacy
• Human rights policy
• International drug control
• Public health policy

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

The Global Commission on Drug Policy is an international advocacy body that campaigns for evidence-based, human-rights-centered reform of global drug laws and policies. It produces position statements, policy briefs, and convenes influential former heads of state and policy leaders to influence national governments, UN bodies, and international drug control frameworks.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Emerging players

• Release (UK): A UK-based center of expertise on drugs and drug law. Comparable as a specialist NGO advocating for evidence-based, human rights-informed drug policy reform.
• Beckley Foundation: A UK-based drug policy research and advocacy foundation commissioning global scientific reviews on drug policy reform. Comparable as an evidence-led, internationally-oriented drug policy reform advocate.

Broad incumbents

• UNODC (United Nations Office on Drugs and Crime): The UN system body responsible for drug control and crime prevention. Comparable as the principal intergovernmental actor in the global drug policy arena that the Commission seeks to influence.
• World Health Organization (WHO): Geneva-based UN agency whose normative guidance on drug dependence and public health underpins much of the evidence-based reform agenda. Comparable as a Geneva-based, public-health-framed authority relevant to the Commission's advocacy.

Direct peers

• Transform Drug Policy Foundation: A UK-based charity advocating for the end of the global drug war through evidence-based policy reform. Comparable in mission and reform-oriented advocacy approach.
• Drug Policy Alliance: A leading U.S. drug policy reform organization promoting evidence-based alternatives to the war on drugs. Comparable mission and advocacy framing, though primarily U.S.-focused rather than Geneva-based.
• International Drug Policy Consortium (IDPC): A global network of NGOs focused on drug policy reform, based in London with representation in Geneva. Directly comparable as a multi-stakeholder advocacy platform promoting evidence-based, human rights-centered drug policy reform internationally.
• Harm Reduction International: A London-based NGO that advances harm reduction policies and practices globally. Comparable as a human rights- and evidence-driven drug policy advocacy organization engaging with UN drug control bodies.
• Transnational Institute (TNI): An international research and advocacy institute with a long-running drug policy program. Comparable as a globally-oriented, Amsterdam-based think-and-do tank engaging with UN drug policy processes.

Others

• Open Society Foundations – Drug Policy Program: A major philanthropic funder of drug policy reform globally. Comparable as a stakeholder shaping the drug policy ecosystem, though primarily a funder rather than an advocacy commissioner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/gcdp

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Commission On Drug Policy